Composition and methods for treatment and screening
AU2003276131A1
A dry powder oligonucleotide formulation, preparation and its uses
US7405207B2
Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
CA2487399A1
Combination of anti-muscarinic agents and non-glucocorticoid steroids
AU2002256359A1
Antisense and anti-inflammatory based compositions to treat respiratory disorders
WO02085309A2
Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent
WO02085297A2
Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
AU2002303425A1
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
MXPA00004001A
Composition and method for prevention and treatment of.
IL145034D0
Method for validating/invalidating target(s) and pathways
WO0007566A1
A new analgesic, anti-inflammatory and wound healing agent
AU4675699A
Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs
